DGAP-News: STRATEC to present at two upcoming Capital Market Conferences

DGAP-News: STRATEC Biomedical AG / Key word(s): Miscellaneous
STRATEC to present at two upcoming Capital Market Conferences

16.12.2011 / 10:27

---------------------------------------------------------------------

STRATEC to present at two upcoming Capital Market Conferences

Birkenfeld, December 16, 2011

STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) today
announced that the company will present at two international Capital Market
Conferences in January 2012:

30th Annual J.P. Morgan Healthcare Conference
Date: January 9, 2012
Venue: San Francisco, CA, USA

CA Cheuvreux - 11th German Corporate Conference
Date: January 17, 2012
Venue: Frankfurt/Main, Germany

Copies of the company presentation and links to the webcast, if available,
will be provided at www.stratec.com > Investor Relations > Financial
Calendar.


About STRATEC
STRATEC Biomedical Systems AG (www.stratec.com) designs and manufactures
fully automated analyzer systems for its partners in the fields of clinical
diagnostics and biotechnology. These partners market such systems, in
general together with their own reagents, as system solutions to
laboratories, blood banks and research institutes around the world.

The company develops its products on the basis of its own patented
technologies. Shares in the company (ISIN: DE0007289001) are traded in the
Prime Standard segment of the Frankfurt Stock Exchange and are listed in
the TecDAX select index of the German Stock Exchange.

The STRATEC Group consists of the publicly listed parent company STRATEC
Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the
USA, the UK, Switzerland and Romania.

 
Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999
ir@stratec.com
www.stratec.com


End of Corporate News

---------------------------------------------------------------------

16.12.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                
Company:     STRATEC Biomedical AG                                  
             Gewerbestr. 37                                         
             75217 Birkenfeld                                       
             Germany                                                
Phone:       +49 (0)7082 7916 0                                     
Fax:         +49 (0)7082 7916 999                                   
E-mail:      info@stratec.com                                       
Internet:    www.stratec.com                                        
ISIN:        DE0007289001                                           
WKN:         728900                                                 
Listed:      Regulierter Markt in Frankfurt (Prime Standard);       
             Freiverkehr in Berlin, Düsseldorf, München, Stuttgart  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
150058 16.12.2011